Esperion Therapeutics | ESPR - DETTE





DETTE Changement Date
AbbVie USD 67.5B 67.5B 2025-12
Alnylam Pharmaceuticals USD 1.28B 30.06M 2025-12
Alterity Therapeutics Limited AUD 210.39K 120.67K 2023-06
Amarin USD 0 0 2025-03
Amgen USD 54.6B 17M 2025-12
Biogen USD 6.56B 275.1M 2026-03
BioMarin Pharmaceutical USD 1.44B 833.74M 2026-03
Cipla INR 4.38B 231.9M 2025-03
CSL USD 11.96B 219M 2024-12
Cytokinetics USD 1.29B 4.48M 2026-03
Daiichi Sankyo JPY 201.14B 99.81B 2025-09
Eli Lilly USD 42.5B 3.6M 2025-12
Esperion Therapeutics USD 262.92M 1.76M 2024-09
Geron USD 121.99M 76K 2025-12
Grifols EUR 9.23B 626.05M 2024-12
Halozyme Therapeutics USD 2.14B 2.01M 2026-03
Heron Therapeutics USD 149.65M 157K 2024-09
Ionis Pharmaceuticals USD 2.34B 9.5M 2026-03
Merck USD 49.34B 7.97B 2025-12
Minerva Neurosciences USD 0 0 2024-09
Moderna USD 1.31B 571M 2025-12
Nektar Therapeutics USD 0 0 2022-06
Pfizer USD 63.73B 231M 2026-03
PTC Therapeutics USD 286.94M 2.42B 2026-03
Puma Biotechnology USD 89.06M 55.07M 2024-06
Regeneron Pharmaceuticals USD 2.71B 300K 2026-03
Sanofi EUR 20.33B 1.43B 2025-12
Sarepta Therapeutics USD 1.04B 210.44M 2025-12
United Therapeutics USD 200M 100M 2025-03
Vanda Pharmaceuticals USD 4.96M 4.96M 2024-12